Acosta, C.J.; Nordio, F.; Boltz, D.A.; Baldwin, W.R.; Hather, G.; Kpamegan, E.
Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates. Microorganisms 2024, 12, 1177.
https://doi.org/10.3390/microorganisms12061177
AMA Style
Acosta CJ, Nordio F, Boltz DA, Baldwin WR, Hather G, Kpamegan E.
Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates. Microorganisms. 2024; 12(6):1177.
https://doi.org/10.3390/microorganisms12061177
Chicago/Turabian Style
Acosta, Camilo J., Francesco Nordio, David A. Boltz, Whitney R. Baldwin, Greg Hather, and Eloi Kpamegan.
2024. "Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates" Microorganisms 12, no. 6: 1177.
https://doi.org/10.3390/microorganisms12061177
APA Style
Acosta, C. J., Nordio, F., Boltz, D. A., Baldwin, W. R., Hather, G., & Kpamegan, E.
(2024). Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates. Microorganisms, 12(6), 1177.
https://doi.org/10.3390/microorganisms12061177
